Startseite Hereditary vitamin D-resistant rickets: a report of four cases with two novel variants in the VDR gene and successful use of intermittent intravenous calcium via a peripheral route
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Hereditary vitamin D-resistant rickets: a report of four cases with two novel variants in the VDR gene and successful use of intermittent intravenous calcium via a peripheral route

  • Saygın Abalı ORCID logo , Mayuko Tamura , Serap Turan , Zeynep Atay , Pınar Isguven , Tülay Güran , Belma Haliloglu , Serpil Baş , Tsuyoshi Isojima , Sachiko Kitanaka und Abdullah Bereket EMAIL logo
Veröffentlicht/Copyright: 12. Februar 2020

Abstract

Background

Hereditary vitamin D-resistant rickets (HVDRR) is caused by vitamin D receptor (VDR) defects. Patients with HVDRR do not respond to standard doses of calcitriol and oral calcium (Ca) treatment and need to be treated with intravenous Ca (IV-Ca) via a central route. However, central catheter-related complications can cause significant morbidity.

Case presentation

Four unrelated patients with HVDRR presenting with rickets and alopecia totalis were administered intermittent IV-Ca treatment (2–5 times/week) through a peripheral route. No complications such as infection, extravasation or arrhythmias were detected upon peripheral infusion. Peripheral 1–22 months’ duration of IV-Ca normalized parathyroid hormone (PTH) and alkaline phosphatase (ALP) in all patients, after which, oral Ca of 200–400 mg/kg/day and calcitriol of 0.5 μg/kg/day were sufficient to maintain normal PTH levels. Molecular studies on the VDR gene showed a previously reported homozygous c.454C > T (p.Q152*) pathogenic variant in two patients. Two novel homozygous variants in the other two patients were detected: (1) c.756-2A > G, which affects the splice acceptor site, and (2) c.66dupG (p.I23Dfs*20) variant leading to a frameshift that results in a premature stop codon.

Conclusions

Peripheral IV-Ca treatment is an effective and practical alternative treatment mode that provides dramatic clinical benefit in patients with HVDRR.


Corresponding author: Abdullah Bereket, MD, Department of Pediatric Endocrinology and Diabetes, School of Medicine, Marmara University, Dr. Faruk Ayanoglu Caddesi No: 50/11, PC34726 Fenerbahce, Istanbul, Turkey, Phone: +90 (216) 411 64 18, Fax: +90 (216) 411 60 49

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Malloy PJ, Feldman D. Genetic disorders and defects in vitamin D action. Endocrinol Metab Clin North Am 2010;39:333–46.10.1016/j.ecl.2010.02.004Suche in Google Scholar

2. Tiosano D, Hochberg Z. Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab 2009;27:392–401.10.1007/s00774-009-0079-1Suche in Google Scholar

3. Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, et al. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 1997;154:57–73.Suche in Google Scholar

4. Hochberg Z, Tiosano D, Even L. Calcium therapy for calcitriol-resistant rickets. J Pediatr 1992;121:803–8.10.1016/S0022-3476(05)81919-5Suche in Google Scholar

5. Isojima T, Ishizawa M, Yoshimura K, Tamura M, Hirose S, et al. Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR) caused by a VDR mutation: a novel mechanism of dominant inheritance. Bone Reports 2015;2:68–73.10.1016/j.bonr.2015.05.001Suche in Google Scholar PubMed PubMed Central

6. Tamura M, Isojima T, Kawashima M, Yoshida H, Yamamoto K, et al. Detection of hereditary 1,25-hydroxyvitamin D resistant rickets caused by uniparental disomy of chromosome 12 using genome-wide single nucleotide polymorphism array. PLoS ONE 2015;10:e0131157.10.1371/journal.pone.0131157Suche in Google Scholar PubMed PubMed Central

7. Kristjansson K, Rut AR, Hewison M, O’Riordan JL, Hughes MR. Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3. J Clin Invest 1993;92:12–6.10.1172/JCI116539Suche in Google Scholar PubMed PubMed Central

8. Stenson PD, Mort M, Ball EV, Evans K, Hayden M, et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 2017;136:665–77.10.1007/s00439-017-1779-6Suche in Google Scholar PubMed PubMed Central

9. Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation predicton for the deep-sequencing age. Nat Methods 2014;11:361–12.10.1038/nmeth.2890Suche in Google Scholar PubMed

10. Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, et al. VarSome: the human genomic variant search engine. Bioinformatics 2019;35:1978–80.10.1093/bioinformatics/bty897Suche in Google Scholar PubMed PubMed Central

11. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248–9.10.1038/nmeth0410-248Suche in Google Scholar PubMed PubMed Central

12. Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 2015;31:2745–7.10.1093/bioinformatics/btv195Suche in Google Scholar

13. Balsan S, Garabédian M, Larchet M, Gorski AM, Cournot G, et al. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest 1986;77:1661–7.10.1172/JCI112483Suche in Google Scholar

14. Donghi V, Di Frenna M, di Lascio A, Chiumello G, Weber G. Vitamin D dependent rickets, diagnostic and therapeutic difficulties: two case reports. J Pediatr Endocrinol Metab 2011;24:801–5.10.1515/JPEM.2011.214Suche in Google Scholar

15. Papadopoulou A, Bountouvi E, Gole E, Doulgeraki A, Tournis S, et al. Identification of a novel nonsense mutation in the ligand-binding domain of the vitamin d receptor gene and clinical description of two greek patients with hereditary vitamin d-resistant rickets and alopecia. Horm Res Paediatr 2014;82:206–12.10.1159/000362618Suche in Google Scholar

16. Ersoy B, Kiremitci S, Isojima T, Kitanaka S. Successful intermittent intravenous calcium treatment via the peripheral route in a patient with hereditary vitamin D-resistant rickets and alopecia. Horm Res Paediatr 2015;83:67–72.10.1159/000367711Suche in Google Scholar

17. Takeda E, Yokota I, Kawakami I, Hashimoto T, Kuroda Y, et al. Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy. Eur J Pediatr 1989;149:54–7.10.1007/BF02024336Suche in Google Scholar

18. Hochberg Z, Benderli A, Levy J, Vardi P, Weisman Y, et al. 1,25-dihydroxyvitamin D resistance, rickets, and alopecia. Am J Med 1984;77:805–11.10.1016/0002-9343(84)90516-3Suche in Google Scholar

19. McDonnell DP, Scott RA, Kerner SA, O’Malley BW, Pike JW. Functional domains of the human vitamin D3 receptor regulate osteocalcin gene expression. Mol Endocrinol 1989;3:635–44.10.1210/mend-3-4-635Suche in Google Scholar PubMed

Received: 2019-10-14
Accepted: 2020-01-01
Published Online: 2020-02-12
Published in Print: 2020-04-28

©2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. Prevalence of obesity and overweight in Iranian students: a systematic review and meta-analysis
  4. Original Articles
  5. Trends in pediatric obesity management, a survey from the Pediatric Endocrine Society Obesity Committee
  6. Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents
  7. Vitamin D status and its relation to insulin resistance in a Mexican pediatric population
  8. Elevated serum uric acid, hyperuricaemia and dietary patterns among adolescents in mainland China
  9. Is there a relationship between the dietary inflammatory index and metabolic syndrome among adolescents?
  10. New insights into the expression of androgen and estrogen receptors of the appendix testis in congenital cryptorchidism
  11. General properties of autoimmune thyroid diseases and associated morbidities
  12. Comparison of leptin levels in neonates born to mothers with high or low gestational weight gain
  13. Percentile values of serum zinc concentration and prevalence of its deficiency in Iranian children and adolescents: the CASPIAN-V study
  14. Nine-year overview of dyslipidemia management in children with heterozygous familial hypercholesterolemia: a university hospital outpatient lipid clinic project in Northwestern Greece
  15. Gesell Developmental Schedules scores and the relevant factors in children with Down syndrome
  16. Letters to the Editor
  17. Society for Pediatric Radiology (SPR) Child Abuse Committee response regarding Miller, Stolfi and Ayoub’s flawed theories about child abuse and metabolic bone disease
  18. Reply of Miller and Ayoub to Brown et al. Letter to the Editor
  19. Case Reports
  20. Identification of two novel variants in GAA underlying infantile-onset Pompe disease in two Pakistani families
  21. Hereditary vitamin D-resistant rickets: a report of four cases with two novel variants in the VDR gene and successful use of intermittent intravenous calcium via a peripheral route
  22. Variant analysis of HPD genes from two families showing elevated tyrosine upon newborn screening by tandem mass spectrometry (MS/MS)
  23. Challenges in the management of an ignored cause of hyperammonemic encephalopathy: pyruvate carboxylase deficiency
  24. Autoimmune polyglandular syndrome type II with co-manifestation of Addison’s and Graves’ disease in a 15-year-old boy: case report and literature review
Heruntergeladen am 2.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0466/html?lang=de
Button zum nach oben scrollen